SAN DIEGO--(BUSINESS WIRE)--Ambit Biosciences today announced the publication in Nature Biotechnology of kinase profiling data for 38 well-known kinase inhibitors, obtained using Ambit’s high-throughput KINOMEscan™ profiling technology. The study also details a novel approach for quantifying the interactions between compounds and the human kinome. This approach enables the systematic analysis of high-throughput kinase profiling data, which dramatically improves the efficiency of selecting and optimizing the highest quality drug candidates from kinase-focused compound libraries.
